Postdoctoral Position in Microfluidic RNAseq-Based Screening for Optimal T-cell Expansion Protocols (Ref. 2442)
École polytechnique fédérale de Lausanne (EPFL) – Laboratory of Biomedical Microfluidics · Switzerland
Deadline
Open until filled
Degree Level
Postdoctoral
Funding
Fully Funded
Location
On-site
Overview
Postdoc in Prof. Christoph Merten's lab, in collaboration with George Coukos's group, developing microfluidic RNAseq screens to find protocols for rapidly expanding tumour-specific T cells for cancer immunotherapy. Planned start 1 January 2027; apply online with a single PDF of cover letter, CV, research statement and referees.
Eligibility
PhD with training in cell biology and next-generation sequencing; experience with T-cell expansion/therapy; droplet microfluidics (10X Genomics) beneficial.
Nationality: Open to all nationalities
Funding & Benefits
Fixed-term (1 year, renewable) salaried EPFL postdoc; salary not stated in advert.
